Vivax Working Group
2-4 March, 2013Bali, Indonesia
Vivax Working Group Meeting
Program
Workshop: The threat of antimalarial resistance to the elimination of malaria
- Welcome to Indonesia – Dr Ferdinand Laihad, Chair of the National Malaria Control & Elimination Committee, Indonesia
- Introduction to the workshop
- The emerging threat of artemisinin resistance
- Detecting artemisinin resistance in falciparum malaria
- The spread of artemisinin resistance: results from the TRAC trial
- Tracking Antimalarial Drug Resistance
- Laboratory markers for drug resistance
- New in vitro tests to assess artemisinin drug sensitivity in P. falciparum
- Understanding artemisinin resistance in falciparum malaria
- Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy
- Understanding the mechanisms of drug action and parasite resistance
- Treatment and elimination of artemisinin resistant falciparum malaria
- Treatment Options
- Feedback from the report on the Artemisinin Resistance
- Mathematical models of elimination strategies
- Elimination strategies for malaria – role in antimalarial resistance: hotspots and hot-pops (Where and who are they? How do we find them? How can we target them? How do we evaluate it?)
- Antimalarial resistance: country perspectives (Cambodia, Thailand, Vietnam, Indonesia, Malaysia, Philippines)
- Drug resistant P. vivax - phenotypic characterisation
- The emergence and spread of CQR P. vivax
- Defining Antimalarial Efficacy in P. vivax.
- Ex vivo drug susceptibility testing in P. vivax.
- Novel in vitro drug studies in P. vivax.
- Molecular characterisation of drug resistance
- Genotyping of P. vivax clinical trials
- Identifying candidate markers of drug resistance
- Molecular Studies of P. vivax
- Discussion on surveillance and elimination of antimalarial resistance
- Concluding comments and wrap up
Vivax Working Group Meeting
- The APMEN capacity building programme
- Introduction to the APMEN Country Partner Technical Development Program
- Research Update: Feedback from Investigators
- Business Meeting: Review of the vivax working group progress, Proposed 2013 Workplan, Revisiting APMEN VxWG Research Priorities